December 12, 2012

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL 2013 Q1 RESULTS (PDF)

(Aurora, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”), a biopharmaceutical company developing drug
candidates for the prevention and treatment of cancer, today announced its financial results and research and
development update for the quarter ended October 31, 2012.